Cystathionine beta-synthase polymorphisms and hyperhomocysteinaemia: an association study

Area of Science:

• Genetics
• Cardiovascular Disease
• Metabolic Pathways

Background:

• Hyperhomocysteinemia is a known risk factor for arterial and venous thrombosis.
• The enzyme cystathionine beta-synthase (CBS) regulates homocysteine degradation.
• Impaired CBS function may influence homocysteine levels and cardiovascular disease (CVD) risk.

Purpose of the Study:

• To investigate the association between CBS gene polymorphisms and homocysteine concentrations.
• To determine if CBS gene variants are linked to arterial occlusive disease risk.

Main Methods:

• Analysis of two silent polymorphisms (699C-->T, 1080C-->T) and one short tandem repeat (-5697 (GT) STR) in the CBS gene.
• Assessment of fasting and post-methionine load homocysteine levels in 190 patients with arterial occlusive disease and 381 controls.
• Evaluation of linkage disequilibrium between the studied CBS variants.

Main Results:

• No significant differences in CBS genotype frequencies were observed between patients and controls.
• No specific CBS genotype was associated with an increased risk of arterial occlusive disease.
• None of the studied CBS genotypes correlated with elevated fasting, post-load, or increased homocysteine concentrations after methionine loading.

Conclusions:

• Genetic variations within the studied CBS gene regions do not appear to be associated with altered homocysteine concentrations.
• The investigated CBS gene polymorphisms are not linked to an increased risk of arterial occlusive disease.
• Further research may be needed to explore other genetic or environmental factors influencing homocysteine levels and CVD risk.